Listen
TAMIFLU
Reason for request
Maintenance of reimbursement in a limited context.
Favourable opinion for reimbursement as preventive treatment only in a pandemic influenza outbreak situation.
Unfavourable opinion for maintenance of reimbursement in the other situations (for more details, see MA).
Clinical Benefit
| Low |
The clinical benefit of TAMIFLU is low in the context of preventive treatment in an established or potential influenza pandemic scenario. |
| Insufficient |
In the context of influenza prevention, the clinical benefit of TAMIFLU is insufficient in the other situations (as prophylaxis during seasonal influenza epidemics). The clinical benefit of TAMIFLU is insufficient to justify its funding by the French national health insurance system in the context of the curative treatment of influenza in the event of a seasonal epidemic or influenza pandemic. |
